535
Views
8
CrossRef citations to date
0
Altmetric
Article Addendum

A mechanism of retinal protection from light-induced degeneration by hydrogen sulfide

&
Pages 169-171 | Published online: 01 Mar 2012

Figures & data

Figure 1. When retinal photoreceptor cells are exposed to light, cGMP-gated channels are closed and the cell membrane is hyperpolarized. The intracellular concentrations of Ca2+ in photoreceptor cells are decreased to approximately 10 nM, which activates 3MST/CAT to produce H2S. H2S activates vacuolar-type H+-ATPase in horizontal cells to released H+ that suppresses the activity of voltage gated Ca2+ channels in photoreceptor cells. By this mechanism H2S maintains intracellular Ca2+ in low levels. Excessive light exposure leads to photoreceptor degeneration caused by reactive oxygen species and elevated intracellular concentrations of Ca2+. The regulation of Ca2+ by endogenous H2S may fail by the excessive levels of light, and the photoreceptor cell degeneration occurs. Even under such conditions the enhancement of 3MST/CAT pathway or the administration of H2S may have clinical benefit for diseases with retinal cell degeneration.

Figure 1. When retinal photoreceptor cells are exposed to light, cGMP-gated channels are closed and the cell membrane is hyperpolarized. The intracellular concentrations of Ca2+ in photoreceptor cells are decreased to approximately 10 nM, which activates 3MST/CAT to produce H2S. H2S activates vacuolar-type H+-ATPase in horizontal cells to released H+ that suppresses the activity of voltage gated Ca2+ channels in photoreceptor cells. By this mechanism H2S maintains intracellular Ca2+ in low levels. Excessive light exposure leads to photoreceptor degeneration caused by reactive oxygen species and elevated intracellular concentrations of Ca2+. The regulation of Ca2+ by endogenous H2S may fail by the excessive levels of light, and the photoreceptor cell degeneration occurs. Even under such conditions the enhancement of 3MST/CAT pathway or the administration of H2S may have clinical benefit for diseases with retinal cell degeneration.